Comparison of BCG Tokyo172 Strain Induction Therapy Between Low Dose and Standard Dose for Non-Muscle Invasive Bladder Cancer: Intravesical Instillation of BCG Tokyo172 Strain

Objectives: The aim of this study was to identify factors that predict recurrence by comparing low-dose and standard-dose Bacillus Calmette-Guérin (BCG) induction therapy in patients with non-muscle invasive bladder cancer (NMIBC). Methods: A total of 273 consecutive NMIBC patients who received low-...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Hideyuki Isobe, Fumitaka Shimizu, Takeshi Ieda, So Nakamura, Naoko Takazawa, Hanna Suetsugu, Kazunori Kajino, Shu Hirai, Hisashi Hirano, Katsuhito Yuzawa, Shigeo Horie
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	MDPI AG 2025-01-01
Serie:	Biomedicines
Soggetti:	non-muscle invasive bladder cancer low-dose BCG standard-dose BCG intravesical induction therapy
Accesso online:	https://www.mdpi.com/2227-9059/13/1/174
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!